MedTrace Logo

Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

NCT00373178 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-11-02

No results posted yet for this study

Summary

The aim of the present study is to investigate the influence of several anti-diabetic regimens (metformin,glitazone,sulfonylurea,glinidine) and diet on metabolic parameters in patients with recently diagnosed type 2 diabetes.

Conditions

Interventions

DRUG

rosiglitazone

DRUG

metformin

DRUG

Anti-diabetic medications

Sponsors & Collaborators

  • University of Athens

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Miltiadis Alevizos, PhD · University Hospital AHEPA,Thessaloniki,Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-01-31
Completion
2008-06-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00373178 on ClinicalTrials.gov